SCHEMBL5309015

SCHEMBL5309015

CCS(=O)(=O)N1CCN(c2ccc(NC(=O)C3CCc4cc(F)cc(N5CCN(C)CC5)c4O3)cc2)CC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1B P28222 6/20 0.65
▸ KCNH2 Q12809 1/20 0.65
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ SMN1; SMN2 Q16637 6/20 0.41
▸ RAD52 P43351 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HTR1A P08908 1/20 0.39
▸ HTR1D P28221 1/20 0.39
▸ HTR2A P28223 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ GAA P10253 1/20 0.38
▸ NPC1 O15118 3/20 0.38
▸ RAB9A P51151 3/20 0.38
▸ LMNA P02545 2/20 0.38
▸ ALOX15 P16050 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5311017 0.92 HTR1B (0.66) HTR1BKCNH2MEN1KMT2AALDH1A1
SCHEMBL4597945 0.92 HTR1B (0.66) HTR1BKCNH2MEN1KMT2AALDH1A1
SCHEMBL4250243 0.92 HTR1B (0.71) HTR1BKCNH2MEN1KMT2ASMN1; SMN2
SCHEMBL4252027 0.89 HTR1B (0.81) HTR1BKCNH2MEN1KMT2AALDH1A1
SCHEMBL5308451 0.89 HTR1B (0.78) HTR1BKCNH2MEN1KMT2AALDH1A1
SCHEMBL4246690 0.88 HTR1B (0.62) HTR1BKCNH2KMT2AALDH1A1CYP2C19
SCHEMBL14529770 0.88 HTR1B (0.66) HTR1BKCNH2MEN1KMT2ASMN1; SMN2
SCHEMBL14525372 0.88 HTR1B (0.62) HTR1BKCNH2MEN1KMT2AALDH1A1
SCHEMBL4247598 0.87 HTR1B (0.65) HTR1BKCNH2MEN1KMT2AALDH1A1
SCHEMBL5308292 0.87 HTR1B (0.63) HTR1BKCNH2MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007053093-A1 CHROMAN COMPOUNDS AS 5 HT1B ANTAGONISTS ASTRAZENECA AB (SE) 2007-05-10 — — WO claimed
WO-2020183011-A1 HTR1D INHIBITORS AND USES THEREOF IN THE TREATMENT OF CANCER INSTITUT CURIE (FR) 2020-09-17 — — WO disclosed
WO-2007053093-A1 CHROMAN COMPOUNDS AS 5 HT1B ANTAGONISTS ASTRAZENECA AB (SE) 2007-05-10 — — WO disclosed
WO-2007053093-A1 CHROMAN COMPOUNDS AS 5 HT1B ANTAGONISTS ASTRAZENECA AB (SE) 2007-05-10 — — WO disclosed
Send feedback